» Articles » PMID: 10371510

Inducible Cyclooxygenase May Have Anti-inflammatory Properties

Overview
Journal Nat Med
Date 1999 Jun 17
PMID 10371510
Citations 383
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclooxygenase (COX) has two isoforms. Generally, COX 1 is constitutively expressed in most tissues, where it maintains physiological processes; inducible COX 2 is considered a pro-inflammatory enzyme and a chief target for the treatment of inflammatory diseases. Here we present evidence that COX 2 may have anti-inflammatory properties. In carrageenin-induced pleurisy in rats, the predominant cells at 2 hours are polymorphonuclear leucocytes, whereas mononuclear cells dominate from 24 hours until resolution at 48 hours. In this model, COX 2 protein expression peaked initially at 2 hours, associated with maximal prostaglandin E2 synthesis. However, at 48 hours there was a second increase in COX 2 expression, 350% greater than that at 2 hours. Paradoxically, this coincided with inflammatory resolution and was associated with minimal prostaglandin E2 synthesis. In contrast, levels of prostaglandin D2, and 15deoxy delta(12-14)prostaglandin J2 were high at 2 hours, decreased as inflammation increased, but were increased again at 48 hours. The selective COX 2 inhibitor NS-398 and the dual COX 1/COX 2 inhibitor indomethacin inhibited inflammation at 2 hours but significantly exacerbated inflammation at 48 hours. This exacerbation was associated with reduced exudate prostaglandin D2 and 15deoxy delta(12-14)prostaglandin J2 concentrations, and was reversed by replacement of these prostaglandins. Thus, COX 2 may be pro-inflammatory during the early phase of a carrageenin-induced pleurisy, dominated by polymorphonuclear leucocytes, but may aid resolution at the later, mononuclear cell-dominated phase by generating an alternative set of anti-inflammatory prostaglandins.

Citing Articles

Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation.

Cutolo E, Campitiello R, Di Dato V, Orefice I, Angstenberger M, Cutolo M Mar Drugs. 2025; 23(2).

PMID: 39997210 PMC: 11857744. DOI: 10.3390/md23020086.


The Effect of Meloxicam on Inflammatory Response and Oxidative Stress Induced by in Bovine Mammary Epithelial Cells.

Liu K, Qiu S, Fang L, Cui L, Dong J, Guo L Vet Sci. 2024; 11(12).

PMID: 39728947 PMC: 11680352. DOI: 10.3390/vetsci11120607.


Haptoglobin buffers lipopolysaccharides to delay activation of NFκB.

Zein L, Grossmann J, Swoboda H, Borgel C, Wilke B, Awe S Front Immunol. 2024; 15:1401527.

PMID: 39416789 PMC: 11479958. DOI: 10.3389/fimmu.2024.1401527.


Colostrum-derived extracellular vesicles: potential multifunctional nanomedicine for alleviating mastitis.

Xiong Y, Shen T, Lou P, Yang J, Kastelic J, Liu J J Nanobiotechnology. 2024; 22(1):627.

PMID: 39407245 PMC: 11481564. DOI: 10.1186/s12951-024-02926-2.


ELIXCYTE, an Allogenic Adipose-Derived Stem Cell Product, Mitigates Osteoarthritis by Reducing Inflammation and Preventing Cartilage Degradation In Vitro.

Chen Y, Hung Y, Chen C, Chen Y, Tsai T, Yang J Curr Issues Mol Biol. 2024; 46(8):8395-8406.

PMID: 39194712 PMC: 11352429. DOI: 10.3390/cimb46080495.